title: Drug-review deadlines and safety problems.
authors.forename: Clark
authors.initials: C
authors.lastname: Nardinelli
authors.forename: Michael
authors.initials: M
authors.lastname: Lanthier
authors.forename: Robert
authors.initials: R
authors.lastname: Temple
mesh_terms: D017277:Drug Approval; D004348:Drug Labeling; D064420:Drug-Related Side Effects and Adverse Reactions; D033161:Government Regulation; D011358:Product Surveillance, Postmarketing; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration